Investor Relations

MEDICLIN at a glance: Management Board, company profile, key data on business development and other important key data.

Financial news and meetings

Annual General Meeting

Information and documents relating to Annual General Meeting.

Financial News

04May

2023

Encouraging development of Group sales in the first quarter of 2023

04May

2023

Mercurius Health acquires Robert Janker Klinik in Bonn, Germany, previously owned by MEDICLIN

31March

2023

Group sales and Group operating result above previous year − cautious outlook for 2023

28February

2023

Disclosure of the preliminary figures of the 2022 financial year

02November

2022

Group sales and Group operating result above previous year − stable capacity utilization, energy costs weigh on result

27October

2022

Disclosure of Significant Transactions with Related Parties pursuant to Section 111c of the German Stock Corporation Act (AktG)

Financial Calendar

28. February 2023

Disclosure of the preliminary figures for the 2022 financial year

31. March 2023

Annual press and analysts’ conference for the 2022 financial year

04. May 2023

Publication of the interim report from 1 January 2023 to 31 March 2023

15. June 2023

Annual General Meeting

31. July 2023

Publication of the interim report from 1 January 2023 to 30 June 2023

03. November 2023

Publication of the interim report from 1 January 2023 to 30 September 2023

Sign-up-Service

We inform our shareholders and the interested public regulary about all the information relevant for investors. Register and you will receive the latest news and information about upcoming events by e-mail.

Corporate Governance

Our corporate governance report creates transparency about the corporate governance self-understanding of MEDICLIN.

Share price & charts

Track the price of the MEDICLIN-share on various stock exchanges in Germany.

Facts & Figures

Management Board, company profile, key data on business development and other important key data

Financial publications

Please download the current interim reports the annual reports as pdf.

Gabriele Eberle

Leitung Unternehmenskommunikation, Pressesprecherin

Tel.: +49 781 488 180
Fax.: +49 781 488 184
Write message

Alexandra Mühr

Investor Relations

Tel.: +49 781 488 326
Fax.: +49 781 488 184
Write message

Investor Relations

Financial news and meetings

Annual General Meeting

Financial News

Financial Calendar

Sign-up-Service

Corporate Governance

Corporate Governance

Share price & charts

Share price & charts

Facts & Figures

Facts & Figures

Financial publications

Financial publications

Your Contacts